Intra-Cellular Therapies to Present at the Canaccord Genuity 41st Annual Growth Conference
Intra-Cellular Therapies, a biopharmaceutical company focused on CNS disorders, announced that CEO Sharon Mates, Ph.D., will present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021, at 2:30 pm PT. The event will be available via live and archived webcast on the company's website. Intra-Cellular Therapies is known for its innovative approaches in developing treatments for psychiatric and neurologic diseases rooted in Nobel prize-winning research.
- None.
- None.
NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the Canaccord Genuity 41st Annual Growth Conference on Thursday, August 12, 2021 at 2:30 pm PT.
The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.
Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006
Source: Intra-Cellular Therapies Inc.
FAQ
When is the presentation by Intra-Cellular Therapies' CEO scheduled?
Where can I watch the Intra-Cellular Therapies presentation?
What is the focus of Intra-Cellular Therapies?
Who is the CEO of Intra-Cellular Therapies?
What type of research does Intra-Cellular Therapies utilize?
